Header cover image

Canadian (TSX) Life Sciences Industry Analysis

UpdatedSep 15, 2023
DataAggregated Company Financials
Companies4
  • 7D-4.5%
  • 3M-15.8%
  • 1Y-17.5%
  • YTD-8.7%

Over the last 7 days, the Life Sciences industry has dropped 6.2%, driven by a pullback from Sona Nanotech of 9.5%. On the other hand Rapid Dose Therapeutics is actually up 27%. The industry has fallen 18% in the last year.

Industry Valuation and Performance

Has the Canadian Life Sciences Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 16 Sep 2023CA$196.4mCA$23.7m-CA$24,644,997.00n/a-8x8.3x
Mon, 14 Aug 2023CA$197.4mCA$23.5m-CA$24,780,404.00n/a-8x8.4x
Wed, 12 Jul 2023CA$198.9mCA$23.5m-CA$24,780,404.00n/a-8x8.5x
Fri, 09 Jun 2023CA$174.0mCA$22.5m-CA$25,042,100.00n/a-6.9x7.7x
Sun, 07 May 2023CA$173.7mCA$22.5m-CA$24,991,382.00n/a-6.9x7.7x
Tue, 04 Apr 2023CA$188.7mCA$23.0m-CA$29,977,765.0039x-6.3x8.2x
Thu, 02 Mar 2023CA$192.4mCA$23.0m-CA$29,977,765.0039x-6.4x8.4x
Sat, 28 Jan 2023CA$190.8mCA$22.4m-CA$30,499,829.0039x-6.3x8.5x
Mon, 26 Dec 2022CA$190.2mCA$22.4m-CA$30,499,829.0035.1x-6.2x8.5x
Wed, 23 Nov 2022CA$198.0mCA$21.8m-CA$30,309,915.0039.1x-6.5x9.1x
Fri, 21 Oct 2022CA$214.2mCA$21.7m-CA$30,373,079.0072.1x-7.1x9.9x
Sun, 18 Sep 2022CA$201.7mCA$21.7m-CA$30,373,079.0076.6x-6.6x9.3x
Tue, 16 Aug 2022CA$208.2mCA$21.9m-CA$23,995,882.0021.2x-8.7x9.5x
Thu, 14 Jul 2022CA$159.0mCA$21.5m-CA$26,689,749.0020.5x-6x7.4x
Sat, 11 Jun 2022CA$179.6mCA$21.5m-CA$26,689,749.0019.9x-6.7x8.4x
Mon, 09 May 2022CA$213.7mCA$21.5m-CA$26,635,227.0018.6x-8x9.9x
Wed, 06 Apr 2022CA$200.4mCA$21.6m-CA$23,635,914.0025.2x-8.5x9.3x
Fri, 04 Mar 2022CA$181.1mCA$21.3m-CA$21,103,914.0027.3x-8.6x8.5x
Sun, 30 Jan 2022CA$224.5mCA$20.9m-CA$20,076,847.0026.6x-11.2x10.7x
Tue, 28 Dec 2021CA$238.7mCA$20.9m-CA$20,076,847.0028x-11.9x11.4x
Thu, 25 Nov 2021CA$254.7mCA$21.0m-CA$14,997,109.0030x-17x12.1x
Sat, 23 Oct 2021CA$243.0mCA$20.7m-CA$14,899,797.0026.6x-16.3x11.8x
Mon, 20 Sep 2021CA$255.0mCA$20.7m-CA$11,409,216.0020.5x-22.4x12.4x
Wed, 18 Aug 2021CA$244.9mCA$20.7m-CA$11,409,216.0020.4x-21.5x11.9x
Wed, 02 Jun 2021CA$208.1mCA$19.7m-CA$8,769,932.0023.9x-23.7x10.6x
Sat, 06 Mar 2021CA$332.2mCA$18.4m-CA$3,146,070.0063x-105.6x18.1x
Tue, 08 Dec 2020CA$169.9mCA$17.7m-CA$2,528,358.00131.1x-67.2x9.6x
Price to Earnings Ratio

-68.1x


Total Market Cap: CA$233.3mTotal Earnings: -CA$3,428,320.00Total Revenue: CA$16.1mTotal Market Cap vs Earnings and Revenue0%0%0%
Canadian Life Sciences Industry Price to Earnings3Y Average -27.3x202120222023
Current Industry PE
  • Investors are pessimistic on the Canadian Life Sciences industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 10.7x is higher than the industry's current PS ratio of 8.4x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences industry have deteriorated over the last three years.
  • Meanwhile revenues for these companies have grown 14% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Trends

Which industries have driven the changes within the Canadian Healthcare industry?

CA Market2.58%
Healthcare5.78%
Life Sciences-4.54%
Clinical Research and Equipment-4.54%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
TELI Telescope InnovationsCA$0.2720.0%
+CA$2.4m
3.8%PS4.9x
DOSE Rapid Dose TherapeuticsCA$0.1215.0%
+CA$1.6m
n/aPS13.3x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

DOSE

CA$0.12

Rapid Dose Therapeutics

7D

15.0%

1Y

n/a

TELI

CA$0.27

Telescope Innovations

7D

20.0%

1Y

3.8%

SONA

CA$0.19

Sona Nanotech

7D

-2.6%

1Y

111.1%